RING1
ring finger protein 1, the group of Ring finger proteins
Basic information
Region (hg38): 6:33208500-33212722
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RING1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 15 | 16 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| inframe indel | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| splice region | 0 | |||||
| non coding | 0 | |||||
| Total | 0 | 0 | 15 | 1 | 1 |
Variants in RING1
This is a list of pathogenic ClinVar variants found in the RING1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
| Position | Type | Phenotype | Significance | ClinVar |
|---|---|---|---|---|
| 6-33208848-A-G | not specified | Uncertain significance (May 18, 2022) | ||
| 6-33209928-C-T | not specified | Uncertain significance (Jan 25, 2024) | ||
| 6-33209959-G-A | Uncertain significance (Jul 29, 2021) | |||
| 6-33210005-C-T | Benign (Jan 01, 2023) | |||
| 6-33210015-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
| 6-33210063-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
| 6-33211273-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
| 6-33211285-G-A | not specified | Likely benign (Jul 28, 2021) | ||
| 6-33211324-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
| 6-33211328-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
| 6-33211328-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
| 6-33211328-G-T | not specified | Uncertain significance (Oct 27, 2022) | ||
| 6-33211430-C-T | not specified | Uncertain significance (Aug 23, 2021) | ||
| 6-33211451-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
| 6-33211462-A-C | not specified | Uncertain significance (Jun 22, 2021) | ||
| 6-33211802-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
| 6-33211888-G-C | not specified | Uncertain significance (May 23, 2023) | ||
| 6-33211901-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
| 6-33211908-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
| 6-33211995-C-T | not specified | Uncertain significance (Dec 21, 2023) |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RING1 | protein_coding | protein_coding | ENST00000374656 | 6 | 4228 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.649 | 0.351 | 125716 | 0 | 6 | 125722 | 0.0000239 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.56 | 133 | 246 | 0.541 | 0.0000155 | 2554 |
| Missense in Polyphen | 3 | 15.481 | 0.19379 | 168 | ||
| Synonymous | -0.0676 | 100 | 99.1 | 1.01 | 0.00000569 | 873 |
| Loss of Function | 3.07 | 3 | 16.4 | 0.183 | 0.00000105 | 178 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000292 | 0.0000292 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000463 | 0.0000462 |
| European (Non-Finnish) | 0.0000388 | 0.0000352 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Constitutes one of the E3 ubiquitin-protein ligases that mediate monoubiquitination of 'Lys-119' of histone H2A, thereby playing a central role in histone code and gene regulation. H2A 'Lys-119' ubiquitination gives a specific tag for epigenetic transcriptional repression and participates in X chromosome inactivation of female mammals. Essential component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones, rendering chromatin heritably changed in its expressibility. Compared to RNF2/RING2, it does not have the main E3 ubiquitin ligase activity on histone H2A, and it may rather act as a modulator of RNF2/RING2 activity. {ECO:0000269|PubMed:16359901}.;
- Pathway
- Notch Signaling Pathway;Notch;Signal Transduction;Gene expression (Transcription);RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;the prc2 complex sets long-term gene silencing through modification of histone tails;Transcriptional Regulation by E2F6;Generic Transcription Pathway;Oxidative Stress Induced Senescence;SUMOylation of DNA damage response and repair proteins;Cellular Senescence;SUMOylation of chromatin organization proteins;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;RNA Polymerase II Transcription;SUMOylation;Cellular responses to external stimuli;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;Intracellular signaling by second messengers;Transcriptional regulation by RUNX1
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.192
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.386
- hipred
- Y
- hipred_score
- 0.717
- ghis
- 0.562
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.959
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ring1
- Phenotype
- skeleton phenotype;
Gene ontology
- Biological process
- anterior/posterior pattern specification;histone H2A monoubiquitination;negative regulation of transcription, DNA-templated;camera-type eye morphogenesis;regulation of catalytic activity;negative regulation of G0 to G1 transition
- Cellular component
- sex chromatin;nucleus;nucleoplasm;cytosol;nuclear speck;PcG protein complex;PRC1 complex
- Molecular function
- chromatin binding;protein binding;transferase activity;metal ion binding;ubiquitin-protein transferase activator activity